Report for: Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial

Title	Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial
Published in	Trials, December 2021
DOI	10.1186/s13063-021-05885-3
Pubmed ID	34924020
Authors	Cecilie Siggaard Knoph, Mathias Ellgaard Cook, Camilla Ann Fjelsted, Srdan Novovic, Michael Bau Mortensen, Liv Bjerre Juul Nielsen, Mark Berner Hansen, Jens Brøndum Frøkjær, Søren Schou Olesen, Asbjørn Mohr Drewes

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Denmark	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	1	50%
Practitioners (doctors, other healthcare professionals)	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	21	100%

Readers by professional status	Count	As %
Student > Ph. D. Student	4	19%
Student > Bachelor	2	10%
Unspecified	2	10%
Researcher	2	10%
Student > Master	1	5%
Other	3	14%
Unknown	7	33%

Readers by discipline	Count	As %
Medicine and Dentistry	4	19%
Unspecified	2	10%
Nursing and Health Professions	2	10%
Immunology and Microbiology	1	5%
Business, Management and Accounting	1	5%
Other	2	10%
Unknown	9	43%

Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled…